Getting your player ready...
WASHINGTON — Cosmetic drug and device maker Allergan said late Wednesday it received approval to market its stomach- shrinking Lap-Band to millions more patients who are less obese than those currently using the device.
The Food and Drug Administration expanded approval to patients with a body-mass index between 30 and 40 and one weight-related medical condition, such as diabetes or high blood pressure.
